Selective Estrogen Receptor Degraders (SERDs): A Promising Strategy for Estrogen Receptor Positive Endocrine-Resistant Breast Cancer-Reference-Cited by-同舟云学术

Selective Estrogen Receptor Degraders (SERDs): A Promising Strategy for Estrogen Receptor Positive Endocrine-Resistant Breast Cancer

Published:2020-11-02 Issue:24 Volume:63 Page:15094-15114
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Lu Yunlong¹²,Liu Wukun¹³⁴^ORCID

Affiliation:

1. School of Medicine & Holistic Integrative Medicine, Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, Nanjing University of Chinese Medicine, Nanjing 210023, China

2. Department of Pharmaceutical Sciences, College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois 60612, United States

3. State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, P. R. China

4. State Key Laboratory of Coordination Chemistry, Nanjing University, Nanjing 210023, P. R. China

Funder

Jiangsu Provincial Department of Education

State Key Laboratory of Natural Medicines

Six Talent Peaks Project in Jiangsu Province

National Natural Science Foundation of China

Priority Academic Program Development of Jiangsu Higher Education Institutions

State Key Laboratory of Coordination Chemistry, Nanjing University

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.0c00913

Reference178 articles.

1. ErbB family receptor inhibitors as therapeutic agents in breast cancer: Current status and future clinical perspective

2. Metastatic Behavior of Breast Cancer Subtypes

3. Molecular portraits of human breast tumours

4. Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer

5. Treatment of Breast Cancer

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The anti-aromatase and anti-estrogenic activity of plant products in the treatment of estrogen receptor-positive breast cancer;The Journal of Steroid Biochemistry and Molecular Biology;2024-10

2. Discovery of novel quinoline scaffold selective estrogen receptor degraders (SERDs) for treatment of ER positive breast cancer with enhanced antiproliferative bioactivity through immunogenic cell death (ICD) effects;European Journal of Medicinal Chemistry;2024-09

3. New Zosteropenillines and Pallidopenillines from the Seagrass-Derived Fungus Penicillium yezoense KMM 4679;Marine Drugs;2024-07-17

4. Structure–Activity Relationship Study of Tris-Benzamides as Estrogen Receptor Coregulator Binding Modulators;ACS Pharmacology & Translational Science;2024-06-25

5. Targeting the crosstalk between estrogen receptors and membrane growth factor receptors in breast cancer treatment: Advances and opportunities;Biomedicine & Pharmacotherapy;2024-06